BEEPEN-VK
Clinical safety rating: caution
Comprehensive clinical and safety monograph for BEEPEN-VK (BEEPEN-VK).
Penicillin V potassium is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This disrupts the cross-linking of peptidoglycan chains, leading to cell lysis and death. It is bactericidal against susceptible organisms.
| Metabolism | Penicillin V is primarily metabolized by hydrolysis to penicilloic acid, mainly in the liver. It is excreted largely unchanged in urine via renal tubular secretion. |
| Excretion | Primarily renal (70-80% as unchanged drug), with minor biliary/fecal excretion. Renal clearance is via tubular secretion and glomerular filtration. |
| Half-life | Terminal elimination half-life is 0.7-1.4 hours in patients with normal renal function; prolonged to 3-20 hours in severe renal impairment (CrCl <10 mL/min). |
| Protein binding | 75-89% bound, primarily to albumin and to a lesser extent to alpha-1-acid glycoprotein. |
| Volume of Distribution | 0.3-0.4 L/kg; represents distribution into total body water and moderate tissue penetration. |
| Bioavailability | Oral: 30-60% (variable due to acid lability and first-pass metabolism); Intramuscular: 100%. |
| Onset of Action | Oral: 30-60 minutes (peak serum concentrations 1-2 hours); Intramuscular: 15-30 minutes (peak 0.5-2 hours). |
| Duration of Action | Bactericidal effect persists 4-6 hours; requires frequent dosing (every 6 hours) for continuous coverage. |
250-500 mg orally every 6 hours for mild to moderate infections; 500 mg orally every 6 hours for severe infections; maximum 4 g/day.
| Dosage form | TABLET |
| Renal impairment | CrCl >50 mL/min: no adjustment; CrCl 10-50 mL/min: 250-500 mg every 6-8 hours; CrCl <10 mL/min: 250-500 mg every 12-24 hours; hemodialysis: 250-500 mg every 24 hours, with an additional dose after dialysis. |
| Liver impairment | No specific guidelines; use with caution in severe hepatic impairment; no dose adjustment recommended for mild to moderate Child-Pugh A or B; Child-Pugh C: consider dose reduction and monitor for adverse effects. |
| Pediatric use | Children >1 month: 25-50 mg/kg/day divided every 6 hours; severe infections: up to 100 mg/kg/day divided every 6 hours; maximum 4 g/day. |
| Geriatric use | No specific dose adjustment; monitor renal function and adjust based on CrCl; elderly may be more susceptible to adverse effects (e.g., Clostridium difficile infection). |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for BEEPEN-VK (BEEPEN-VK).
| Breastfeeding | Penicillin V is excreted into breast milk in low concentrations (M/P ratio approximately 0.2-0.3). It is generally considered compatible with breastfeeding due to minimal risk of adverse effects in the infant. However, potential for alteration of infant gut flora or allergic sensitization exists; observe infant for diarrhea, rash, or candidiasis. |
| Teratogenic Risk | Penicillin V (BEEPEN-VK) is classified as FDA Pregnancy Category B. Animal reproduction studies have not demonstrated a risk to the fetus, and there are no adequate and well-controlled studies in pregnant women. However, penicillin V is generally considered safe in all trimesters when used at recommended doses. No teratogenic effects have been consistently reported in humans. |
■ FDA Black Box Warning
No FDA boxed warning exists for penicillin V potassium.
| Serious Effects |
["Hypersensitivity to penicillins or any component","Previous serious allergic reaction (e.g., anaphylaxis) to beta-lactams"]
| Precautions | ["Hypersensitivity reactions (anaphylaxis, rash, urticaria)","Cross-allergenicity with cephalosporins","Superinfection with prolonged use","Clostridium difficile-associated diarrhea","Use in renal impairment may require dose adjustment"] |
| Food/Dietary | Take penicillin V potassium on an empty stomach, at least 1 hour before or 2 hours after meals. Avoid acidic beverages (e.g., fruit juices, cola) as they can degrade the drug. No significant interactions with other foods; however, calcium-rich foods (dairy) are not contraindicated but may slightly delay absorption. Avoid alcohol during therapy as it may increase side effects like nausea. |
Loading safety data…
| Fetal Monitoring | No specific maternal-fetal monitoring is required beyond standard prenatal care. Monitor for signs of allergic reaction or superinfection in the mother. In neonates or high-risk pregnancies, monitor renal and hepatic function if prolonged therapy is used. |
| Fertility Effects | No known adverse effects on human fertility. Animal studies have not shown impaired fertility at therapeutic doses. |
| Clinical Pearls | BEEPEN-VK (penicillin V potassium) is acid-stable and can be taken with or without food, but absorption is slightly better on an empty stomach. For streptococcal pharyngitis, continue therapy for 10 days to prevent rheumatic fever. In renal impairment, dose adjustment may be necessary for high doses; no adjustment needed for typical oral doses. Monitor for hypersensitivity reactions, including anaphylaxis, especially in patients with history of penicillin allergy. Use with caution in patients with severe renal impairment or seizure disorders. |
| Patient Advice | Take this medication exactly as prescribed, even if you feel better. · Complete the full course of therapy to prevent resistance or recurrence. · Take on an empty stomach (1 hour before or 2 hours after meals) for best absorption. · Do not take with fruit juices or acidic beverages as they may reduce effectiveness. · Notify your doctor if you develop rash, itching, swelling, or difficulty breathing. · Store at room temperature away from moisture and heat; do not refrigerate. · Discard any unused antibiotic after finishing course; do not save for later use. · If you miss a dose, take it as soon as possible unless it is almost time for the next dose; do not double the dose. · Inform your doctor if you are pregnant, breastfeeding, or have kidney disease. |